|
CHD6 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.36999999997578E-06 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.295400E-03 |
| Normal-vs-Stage2 |
1.420060E-03 |
| Normal-vs-Stage3 |
1.74856999999307E-05 |
| Normal-vs-Stage4 |
3.05680000201036E-08 |
| Stage1-vs-Stage2 |
2.297400E-01 |
| Stage1-vs-Stage3 |
2.986200E-02 |
| Stage1-vs-Stage4 |
6.4332999999972E-05 |
| Stage2-vs-Stage3 |
7.117600E-01 |
| Stage2-vs-Stage4 |
1.179430E-01 |
| Stage3-vs-Stage4 |
1.237830E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.10690000002067E-06 |
| Normal-vs-AfricanAmerican |
1.295690E-02 |
| Normal-vs-Asian |
8.086000E-01 |
| Caucasian-vs-AfricanAmerican |
5.173800E-01 |
| Caucasian-vs-Asian |
1.649600E-01 |
| AfricanAmerican-vs-Asian |
3.793000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.19350000005181E-06 |
| Normal-vs-Female |
1.116020E-03 |
| Male-vs-Female |
6.027600E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.277600E-02 |
| Normal-vs-Age(41-60Yrs) |
7.797200E-04 |
| Normal-vs-Age(61-80Yrs) |
1.16390000004518E-06 |
| Normal-vs-Age(81-100Yrs) |
3.207400E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.487400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.492400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.100400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.462100E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.804400E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.332000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
3.366400E-01 |
| Normal-vs-Grade 2 |
1.291640E-02 |
| Normal-vs-Grade 3 |
7.04760000025395E-07 |
| Normal-vs-Grade 4 |
1.57220003682568E-09 |
| Grade 1-vs-Grade 2 |
3.254500E-02 |
| Grade 1-vs-Grade 3 |
2.1074999999926E-05 |
| Grade 1-vs-Grade 4 |
6.95759999946866E-07 |
| Grade 2-vs-Grade 3 |
8.156100E-04 |
| Grade 2-vs-Grade 4 |
9.65679999964664E-07 |
| Grade 3-vs-Grade 4 |
1.119960E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.635960E-03 |
| Normal-vs-ccB subtype |
4.231000E-04 |
| ccA subtype-vs-ccB subtype |
3.235200E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.205890E-04 |
| Normal-vs-N1 |
3.151300E-04 |
| N0-vs-N1 |
5.750200E-02 |
|
|
